AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

πŸ‡ΏπŸ‡Ό

GLICLAZIDE in Zimbabwe

11 products registered with MCAZ β€” 11 active

Brand / ProductReg. No.HolderStatusExpires
GLYCET MR-30
TABLET; ORAL
2026/17.7/7373PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTDactive29 Mar 2031
GLYCET MR-60
TABLET, COATED; ORAL
2026/17.7/7372PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTDactive29 Mar 2031
ZIGLIC MR 30
TABLET; ORAL
2026/17.7/7359INNOVATA PHARMACEUTICALSactive17 Mar 2031
ZIGLIC MR 60
TABLET; ORAL
2026/17.7/7360INNOVATA PHARMACEUTICALSactive17 Mar 2031
NONE
TABLET; ORAL
2026/17.7/7286IMPERIAL MEDICAL SOLUTIONSactive3 Feb 2031
DIAGEN MR 30
TABLET; ORAL
2025/17.7/7147MYLAN LABORATORIES LIMITED [OTL]active6 Nov 2030
DIAGEN MR 60
TABLET; ORAL
2025/17.7/7148MYLAN LABORATORIES LIMITED [OTL]active6 Nov 2030
OZICLIDE MR
TABLET; ORAL
2017/17.7/5339SUN PHARMACEUTICAL INDUSTRIES LIMITEDactive1 May 2029
DIABEND
TABLET; ORAL
2001/17.7/3957SKY PHARMACEUTICALS LTDactive31 Dec 2027
GLYCINORM-80
TABLET; ORAL
2003/17.7/4179IPCA LABORATORIES LTDactive31 Dec 2027
MELANOV MR 60
TABLET, COATED; ORAL
2025/17.7/6830MICRO LABS LIMITEDactive31 Dec 2027

GLICLAZIDE β€” MCAZ Registration Details

MCAZ (Zimbabwe) has 11 registered products containing GLICLAZIDE, of which 11 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track GLICLAZIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Gliclazide β€” Zimbabwe (MCAZ) | AfricaRegulatory